| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |